Governance, recording, and multilingual patient workflows matter more than model speed
Operations teams now face a different question about artificial intelligence (AI) than they did two years ago. The choice is no longer whether to pilot; it is how to evaluate vendors in a way that preserves clinician oversight, creates auditable records, and protects regulated communications as AI moves into voice, SMS, and secure messaging channels. As enterprise AI funding rounds accelerate (Qualified Health recently raised $125 million to scale AI at health systems), vendors are positioning to take AI from pilot to production quickly. The operational stakes are straightforward: when an AI assistant touches patient communications or contact-center conversations, the evaluation checklist should include governance, language coverage, recording and retention, and how the vendor will hand off exceptions to human teams.
Getting those items right keeps programs from becoming hidden risk.
The questions most evaluations skip
Most requests for proposal (RFPs) start with model accuracy and speed. Those are necessary, but not sufficient. The hard questions that decide whether a deployment is workable live in the gaps between channels and between people. Here are the staff-level problems that tend to surface:
- Who is accountable when the assistant gives an incorrect or incomplete answer, and how is that accountability documented?
- How are conversations recorded, retained, and made available for review in a way that meets the Health Insurance Portability and Accountability Act (HIPAA) requirements and your internal policies?
- How will the system route a patient who needs escalation to a human, and can the routing respect per-site or per-service escalation contacts?
- How does the vendor measure channel coverage (phone, SMS, and secure messaging), and what languages are supported from day one?
If a vendor cannot answer these questions with concrete detail, the deployment will create more work than it relieves. A quick litmus test is to ask for the vendor’s answers in writing and to see examples of the audit documentation they will produce during routine monitoring. For call recording and compliance specifics, teams should review a vendor checklist similar to why enterprise call recording compliance deserves a vendor checklist.
Per-person workflows and what they demand
What separates a manageable pilot from a maintainable enterprise rollout is how the system treats each person as an independent timeline. A patient who finishes an appointment today will have a different follow-up cadence than one who finished last week. That per-person automation pattern drives three practical requirements.
Language and channel coverage cannot be an afterthought. Programs that rely only on email or web links miss older adults, limited-English households, and people without smartphones. Multilingual delivery and phone-first options matter for measurement validity and access. See our notes on enterprise satisfaction survey programs for how channel mix changes who answers and what the score means.
Escalation needs explicit handoffs. Some responses require clinician review the same day. The evaluation brief should ask vendors to describe how the assistant identifies those responses, how it packages context for the human on call, and what the expected human response window is. Do not accept vague answers about “automated escalation” without a description of the human on-call workflow.
Measurement and monitoring must be part of the offer. Continuous monitoring is not a marketing line; it is a requirement. Vendors should describe what they log, how frequently they run quality reviews, and how their monitoring surfaces drift in the assistant’s behavior. For patient-facing use cases, ask whether the vendor has considered safeguards for agentic AI in patient-facing workflows and how those safeguards are enforced in day-to-day work; a practical primer is available in operational safeguards for agentic AI in patient-facing workflows.
There are honest tradeoffs. Requiring human review on many interactions increases cost and delays, but lowering the human oversight bar raises risk. The right balance depends on the use case. Administrative assistants that answer scheduling questions tolerate more automation than assistants that summarize clinical comments or screen for urgent symptoms.
Three vendor questions worth writing down
- Describe, in concrete terms, how your system creates an auditable record of an interaction that includes the assistant output, the decision to escalate, and who received the escalation.
- What channels and languages are supported from initial deployment, and how do you measure gaps in reach by channel and language?
- Explain how your monitoring program detects model drift or safety regressions, who reviews those alerts, and what the remediation process looks like.
These questions force vendors to move from product marketing to detail. If a vendor cannot answer them, ask whether they will accept a limited-scope pilot contract that binds both parties to a monitoring cadence and agreed remediation actions. That protects the health system while the assistant proves itself in live work.
Remember that compliance is a shared responsibility. Your vendor can support HIPAA-aligned controls and provide encrypted stores, but your organization must define retention policies, access roles, and the point at which a human takes responsibility for clinical decisions. The evaluation and operations teams should own those choices together.
The honest outcome is not that AI will replace staff overnight. AI will absorb routine work and change where humans focus their time. Evaluation that asks the right questions up front reduces the chance that AI deployments become expensive, compliance-exposing experiments. For contact-center teams thinking about recording, monitoring, and AI summaries, a practical starting point is to review secure call recording and transcription approaches in secure call recordings, transcriptions, and AI summaries.
Related coverage: Qualified Health locks in $125M in fresh funding to scale enterprise AI at health systems — Fierce Healthcare